LANCL2 and glioblastoma: Kaplan–Meier survival and multivariate analyses also found that LANCL2 amplification was significantly associated with poor OS (p = 0.018, HR = 2.199) in younger GBM patients (n = 62) (Fig. 3J, Table 6).